Objective
Each year, 1.1 million inhabitants of Europe suffer stroke. Stroke leads to extensive neuronal loss and results in an environment filled with cellular debris, notably myelin debris. The clearance of this debris by microglia is crucial for restoring homeostasis, but it can overwhelm their phagocytic function. Consequently, damaged areas often exhibit microglia with cytoplasmic inclusions known as lipid droplets (LDs). Recent findings by one of the supervisors indicate that microglia in young mice accumulate LDs, with Plin2 being one of the most differentially expressed genes after brain ischemia.
LIMITS aims to characterize the contribution of LDs to the neurological deficits following thrombotic stroke to be exploited as (i) novel markers for monitoring and (ii) novel therapeutic targets. Additionally, we will develop new preclinical models to share with the entire research community.
The objectives are: (i) to establish a new strain of transgenic mice with a deletion of the Plin2 gene in microglia, (ii) to characterize the inflammatory response, lesion volume, and neurological function after ischemic stroke of this new strain, and (iii) to identify new pharmacological approaches targeting LDs for the treatment of ischemic stroke. My expertise in inflammation and metabolic reprogramming, the supervisors' established proficiency in clinical and basic stroke research, the lipid expertise of our collaborators, and the availability of all necessary facilities and training opportunities at the host institution will ensure the success of this research.
LIMITS project has the potential to uncover innovative therapies for ischemic stroke. Furthermore, since LDs have been shown to play a pivotal role not only in ischemic stroke but also in other conditions such as aging, obesity, and cancer, the results from this project are expected to have a significant impact across various disease areas.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine neurology stroke
- medical and health sciences basic medicine physiology homeostasis
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2023-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
08036 BARCELONA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.